HeyJaredErnie Mundell
- Indexed articles, last 90 days
- 3
- Latest publication
- Sep 18, 2026
- Outlet visibility, for Medscape
- Top 50K sites
- Earliest in this view
- Jul 17, 2026
Latest articles
Annual Cancer Report Highlights Advances, Funding Threats (opens the original)
Read excerpt
From new precision therapies to AI-powered detection tools, the past year has seen major advances in cancer care, according to the annual Cancer Progress Reportfrom the American Association for Cancer Research (AACR). This year’s report had plenty of highlights — including new therapies for rarer cancers, expanded uses for molecularly targeted drugs, and long-awaited good news on the cancer vaccine front. At the same, the AACR warned that future progress could be stymied by proposed federal rule
US Cancer Trials Heavily Favor Single Drugs Over Care Issues (opens the original)
Read excerpt
With industry’s role in US cancer clinical trials expanding dramatically in recent decades, a new study raises concerns that drug makers’ focus on single-agent therapies could leave many important questions unanswered. The analysis, of nearly 12,000 cancer trials conducted between 2008 and 2024, found that industry-sponsored studies overwhelmingly tested single therapeutic agents. In contrast, federally funded research often took a broader view — looking at multimodal therapies, safer dosing and
Algorithm Rules Out Pulmonary Embolism in Cancer Patients (opens the original)
Read excerpt
The first randomized trial of its kind concludes that an algorithm widely used to rule out pulmonary embolism (PE) can safely be extended to patients with cancer. As it stands, patients with cancer and suspected PE usually go straight to CT pulmonary angiography (CTPA) for evaluation. But in the new trial, the so-called YEARS algorithm worked just as well as immediate CTPA in ruling out PE — and it allowed 22% of patients to skip the scans. “We have undoubtedly demonstrated in a randomized clini
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Medscape, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.